Ashvattha Therapeutics is a startup based in the United States, most recent round Acquired, 1 tracked investor.
Based in the United States, Ashvattha Therapeutics is a startup. Ashvattha Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Ashvattha Therapeutics was a United States-based biopharmaceutical company focused on the development of therapeutic drugs. It was part of Catalio Capital's portfolio and exited in 2019.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.